XOMA (XOMAP) Expected to Announce Earnings on Thursday

XOMA (NASDAQ:XOMAP) is projected to post its results before the market opens on Thursday, April 30th. Analysts expect XOMA to post earnings of $0.1575 per share and revenue of $13.7310 million for the quarter.

XOMA Stock Performance

XOMAP opened at $26.11 on Thursday. XOMA has a 12 month low of $25.21 and a 12 month high of $30.00. The company has a fifty day simple moving average of $26.09 and a 200 day simple moving average of $26.36.

XOMA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Thursday, April 2nd were given a $0.5391 dividend. The ex-dividend date was Thursday, April 2nd. This represents a $2.16 dividend on an annualized basis and a dividend yield of 8.3%.

XOMA Company Profile

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.